Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for Cardio Diagnostics Holdings (CDIO) over the last 4 years, with Q3 2025 value amounting to -$2939.0.

  • Cardio Diagnostics Holdings' Other Non Operating Income rose 1833.84% to -$2939.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$14849.0, marking a year-over-year decrease of 11072.91%. This contributed to the annual value of -$17576.0 for FY2024, which is 9845.06% up from last year.
  • As of Q3 2025, Cardio Diagnostics Holdings' Other Non Operating Income stood at -$2939.0, which was up 1833.84% from -$4500.0 recorded in Q2 2025.
  • Cardio Diagnostics Holdings' 5-year Other Non Operating Income high stood at $670511.0 for Q1 2023, and its period low was -$1.5 million during Q2 2023.
  • For the 4-year period, Cardio Diagnostics Holdings' Other Non Operating Income averaged around -$98186.8, with its median value being -$4504.0 (2025).
  • Within the past 5 years, the most significant YoY rise in Cardio Diagnostics Holdings' Other Non Operating Income was 126610.61% (2023), while the steepest drop was 257064.72% (2023).
  • Quarter analysis of 4 years shows Cardio Diagnostics Holdings' Other Non Operating Income stood at -$55034.0 in 2022, then surged by 378.14% to $153069.0 in 2023, then crashed by 101.9% to -$2906.0 in 2024, then decreased by 1.14% to -$2939.0 in 2025.
  • Its last three reported values are -$2939.0 in Q3 2025, -$4500.0 for Q2 2025, and -$4504.0 during Q1 2025.